Opioids relieve severe shortness of breath in COPD
Written by Bruce Sylvester | 14 Jun 2012
by Bruce Sylvester – Opioid treatment offers relief and improved quality of life to patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath,
2000 fewer deaths from tobacco related disease since 1998
Written by Bruce Sylvester | 14 Jun 2012
by Bruce Sylvester – A research paper published in ‘Tobacco Control’ by the British Medical Journal (BMJ) shows that tobacco control policies implemented in Ireland between 1998 and… read more.
Greater hearing loss with age among women with diabetes
Written by Bruce Sylvester | 14 Jun 2012
by Bruce Sylvester – Diabetes adds to hearing loss with age among women, if it is not well controlled with medication,
Youth with Type 2 Diabetes get better results with two-drug treatment
Written by Bruce Sylvester | 14 Jun 2012
by Bruce Sylvester – Combination metformin and rosiglitazone is more effective than metformin monotherapy in youth with recent-onset type 2 diabetes,
Green light for new medicines
Written by Gary Finnegan | 14 Jun 2012
Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.
How should advanced therapies be classified?
Written by Gary Finnegan | 14 Jun 2012
Emerging uses of EMA Approved Drugs – by Gary Finnegan – The EMA has launched a public consultation on the classification of advanced therapies.
Tough times for medicines regulator
Written by Gary Finnegan | 14 Jun 2012
Emerging uses of EMA Approved Drugs – by Gary Finnegan – The European Medicines Agency is emerging from a turbulent spell which has seen the departure of one… read more.
Ipilimumab looks promising in shrinking/slowing melanoma brain metastases
Written by Bruce Sylvester | 14 Jun 2012
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Researchers from a phase 2 study published on March 27 in The Lancet Oncology report that ipilimumab,… read more.
Largest study to date confirms efficacy of botulinum toxin treatment for overactive bladder
Written by Bruce Sylvester | 14 Jun 2012
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Results from the largest study yet of the treatment of urinary incontinence with botulinum toxin suggests that… read more.
Statins appear to lower depression risk among heart disease patients
Written by Bruce Sylvester | 14 Jun 2012
Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Heart disease patients who use statins are significantly less likely to develop depression than their counterparts who… read more.
One scan can rule out pregnancy-related DVT
Written by Bruce Sylvester | 14 Jun 2012
Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – One ultrasound scan can safely rule out a diagnosis of deep vein thrombosis (DVT) in women… read more.
Evidence growing that aspirin helps prevent cancer
Written by Bruce Sylvester | 14 Jun 2012
Taken from The Lancet – by Bruce Sylvester – Two papers published in March, 2012 in The Lancet suggest that daily aspirin use can be protective against cancer.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

